MEET OUR TEAM
Alexis Edwards
Provider Database Specialist
Amanda Veeser
HR Manager
Andy Schatz
Chief Financial Officer
Anna Hladilek
Repricing Specialist
Bob Chin
Chief Information Officer
Colin Christiansen
System Administrator
Chris Ammerman
Enterprise Architect
Dean Kohler
Senior Software Developer
Diego Ornelas
Provider Database Coordinator
Gigi Molina
Claims Processing Specialist
Grigoriy Gurariy
Senior Software Developer – Applications
Gwen Flowers
Office/HR Administrative Assistant
Janet Gonzalez
Provider Refund Specialist
Jenny Wendling
Claims Processing Specialist
Jim Higgins
Actuarial Manager
Jim Meyers
Director of Network Development
Justin McConnell
Staff Accountant
Karla Buel
Repricing Specialist
Katie Weiske
Controller
Kelly Ragland
Operations Supervisor
Kia Her
Client Engagement Manager
Lisa Friend
Payment Posting Specialist
Mark Xistris
Chief Strategy Officer
Marie Foley
VP Provider Relations & Actuarial Services
Pamela Malone
Client Engagement Manager
Paul Mueller
Director of Business Development
Paul Young
Systems Engineer – Team Lead
Ptoshia Triplett
Provider Refund Specialist
Rebecca Kirchen
Product Manager
Samuel Frymark
Sr. Quality Assurance Analyst
Scott Schiesser
Sr. Actuarial Analyst
Shamia Morris
Payment Posting Specialist
Terry Rowinski
President
Tina Snortum
VP of Client Engagement
Tom Policelli
CEO
Yolanda Lovett
Client Engagement Coordinator
Scott Lamers
Senior Software Developer
Jhavontae Jones
Software Developer II – Applications
Board of Directors
Elizabeth Schwert
Vice President
SV Health Investors
Tom Policelli
CEO
Health Payment Systems
Jeffrey Holdsberg
Managing Director
Caltius Equity Partners
Tom Flynn
Managing Partner
SV Health Investors
Kelly DeKeyser
Independent Director
Investors
SV Health Investors took a controlling interest in HPS in February 2021.
About SV Health Investors
SV Health Investors is a leading healthcare fund manager investing in tomorrow’s healthcare breakthroughs. SV invests across stages, geographic regions and sectors, with expertise spanning healthcare services/technology, medical products, biotechnology, dementia and public equities. With approximately $2.2B in assets under management and offices in Boston and London, SV has built an extensive network of investment professionals and experienced industry veterans. Since its founding in 1993, SV has invested in more than 175 companies, with more than 75 of these having achieved successful acquisitions or IPOs. For more information, please visit www.svhealthinvestors.com.